| Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy A Goldman, E Maor, D Bomze, JE Liu, J Herrmann, J Fein, RM Steingart, ... Journal of the American College of Cardiology 78 (18), 1800-1813, 2021 | 69 | 2021 |
| Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports A Goldman, D Bomze, R Dankner, H Hod, T Meirson, B Boursi, E Maor British Journal of Clinical Pharmacology 87 (3), 1432-1442, 2021 | 47 | 2021 |
| Ocular adverse events induced by immune checkpoint inhibitors: a comprehensive pharmacovigilance analysis D Bomze, T Meirson, O Hasan Ali, A Goldman, L Flatz, Z Habot-Wilner Ocular immunology and inflammation 30 (1), 191-197, 2022 | 31 | 2022 |
| Incidental abnormal ECG findings and long-term cardiovascular morbidity and all-cause mortality: A population based prospective study A Goldman, H Hod, A Chetrit, R Dankner International Journal of Cardiology 295, 36-41, 2019 | 25 | 2019 |
| Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study A Goldman, E Raschi, T Cukierman-Yaffe, R Dankner, R Shouval, ... European Journal of Preventive Cardiology 29 (9), 1334-1342, 2022 | 23 | 2022 |
| Cardiovascular toxicities of antiangiogenic tyrosine kinase inhibitors: a retrospective, pharmacovigilance study A Goldman, D Bomze, R Dankner, D Fourey, B Boursi, M Arad, E Maor Targeted Oncology 16 (4), 471-483, 2021 | 18 | 2021 |
| Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. T Merison, A Goldman, D Bomze The New England journal of medicine 385 (20), e70-e70, 2021 | 16 | 2021 |
| The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study A Goldman, B Fishman, G Twig, E Raschi, T Cukierman-Yaffe, ... Cardiovascular Diabetology 22 (1), 16, 2023 | 15 | 2023 |
| Adolescent hypertension is associated with stroke in young adulthood: a nationwide cohort of 1.9 million adolescents B Fishman, A Bardugo, Y Zloof, CD Bendor, C Libruder, I Zucker, M Lutski, ... Stroke 54 (6), 1531-1537, 2023 | 3 | 2023 |
| Data for a population based cohort study on abnormal findings of electrocardiograms (ECG), recorded during follow-up periodic examinations, and their association with long-term … A Goldman, H Hod, A Chetrit, R Dankner Data in brief 26, 104474, 2019 | 3 | 2019 |
| Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells A Goldman, E Raschi, J Chapman, BD Santomasso, MC Pasquini, ... Blood 141 (6), 673-677, 2023 | 2 | 2023 |
| Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy D Bomze, L Mutti, A Goldman, G Markel, T Meirson The Lancet Oncology 23 (6), e245, 2022 | 2 | 2022 |
| The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration M Fusaroli, F Salvo, B Begaud, TM AlShammari, A Bate, V Battini, ... Drug safety, 1-15, 2024 | 1 | 2024 |
| The real-world safety of sacubitril/valsartan among older adults (≥ 75): A pharmacovigilance study from the FDA data TT Lerman, N Greenberg, B Fishman, A Goldman, Y Talmor-Barkan, ... International Journal of Cardiology 397, 131613, 2024 | 1 | 2024 |
| Polypharmacy is differentially associated with 20-year mortality among community-dwelling elderly women and men: The Israel Glucose Intolerance, Obesity and Hypertension cohort … L Orenstein, A Chetrit, A Goldman, I Novikov, R Dankner Mechanisms of ageing and development 211, 111788, 2023 | 1 | 2023 |
| Sex specific serum uric acid levels are associated with ischemic changes on ECG and with 20-year all-cause mortality among older adults Y Moshkovits, A Goldman, A Chetrit, R Dankner PloS one 18 (3), e0283839, 2023 | 1 | 2023 |
| For and Against Routine Removal of Peripheral Intravenous Catheters T Meirson, A Goldman, D Bomze JAMA Internal Medicine 182 (4), 455-456, 2022 | 1 | 2022 |
| T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy R Storgard, K Rejeski, MA Perales, A Goldman, R Shouval JAMA oncology, 2024 | | 2024 |
| Mild renal impairment is associated with increased cardiovascular events and all-cause mortality following cancer diagnosis Y Moshkovits, A Goldman, S Tiosano, A Kaplan, M Kalstein, G Bayshtok, ... European Journal of Cancer Prevention 33 (1), 11-18, 2024 | | 2024 |
| The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy I Landego, JR Flynn, A Goldman, SM Devlin, E Luttwak, AL De Abia, ... Blood 142, 6908, 2023 | | 2023 |
Elad MaorInterventional Cardiologist, Sheba Medical CenterVerified email at sheba.health.gov.il
